Case report: Combined intravitreal anti-vascular endothelial growth factor (Avastin®) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma

Acta Ophthalmologica

Volumn 88, Issue 5, 2010, Pages 610-613

  Mennel, Stefan ^a   Meyer, Carsten H ^b   Callizo, Josep ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

anti VEGF; Avastin ; bevacizumab; eye; haemangioma; PDT; photodynamic therapy; retina

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CAPILLARY HEMANGIOMA; CAPILLARY LEAK SYNDROME; CASE REPORT; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LIPID STORAGE; METAMORPHOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINAL JUXTAPAPILLARY CAPILLARY HEMANGIOMA; RETINAL THICKNESS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD; VISUAL SYSTEM PARAMETERS; DRUG ANTAGONISM; INJECTION; MULTIMODALITY CANCER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTOCHEMOTHERAPY; RETINA TUMOR; VITREOUS BODY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEMANGIOMA, CAPILLARY; HUMANS; INJECTIONS; PHOTOCHEMOTHERAPY; RETINAL NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 77954639565     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01449.x     Document Type: Article

References (21)

1. Aggio FB, Melo GB, Höfling-Lima AL Eid Farah M (2006 Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration. Acta Ophthalmol Scand 84 : 831 833.
2. ®) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol 86 : 482 489.
3. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA Giust MJ (2006 Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113 : 363 372.
4. von Buelow M, Pape S Hoerauf H (2007 Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma. Acta Ophthalmol Scand 85 : 114 116.
5. Dahr SS, Cusick M, Rodriguez-Coleman H, Srivastava SK, Thompson DJ, Linehan WM, Ferris FL III. Chew EY (2007 Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina 27 : 150 158.
6. Garcia-Arumí J, Sararols LH, Cavero L, Escalada F Corcóstegui BF (2000 Therapeutic options for capillary papillary hemangiomas. Ophthalmology 107 : 48 54.
7. Gass JD Braunstein R (1980 Sessile and exophytic capillary angiomas of the juxtapapillary retina and optic nerve head. Arch Ophthalmol 98 : 1790 1797.
8. McCabe CM, Flynn HW Jr., Shields CL et al. (2000 Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes. Ophthalmology 107 : 2240 2248.
9. Mennel S, Meyer CH, Eggarter F Peter S (2005 Transient serous retinal detachment in classic and occult choroidal neovascularization after photodynamic therapy. Am J Ophthalmol 140 : 758 760.
10. Mennel S, Hoerle S Meyer CH (2006 Photodynamic therapy in symptomatic parafoveal telangiectasia secondary to Osler-Rendu-Weber disease. Acta Ophthalmol Scand 84 : 273 275.
11. Mennel S, Barbazetto I, Meyer CH, Peter S Stur M (2007a Ocular photodynamic therapy - standard applications and new indications. Part 2. Review of the literature and personal experience. Ophthalmologica 221 : 282 291. (Pubitemid 47339650)
12. Mennel S, Meyer CH, Peter S, Schmidt JC Kroll P (2007b Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature. Acta Ophthalmol Scand 85 : 127 132.
13. Parodi MB, Da Pozzo S Ravalico G (2007 Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia. Acta Ophthalmol Scand 85 : 50 54.
14. Pedersen R, Soliman W, Lund-Andersen H Larsen M (2007 Treatment of choroidal neovascularization using intravitreal bevacizumab. Acta Ophthalmol Scand 85 : 526 533.
15. Rosenfeld PJ, Moshfeghi AA Puliafito CA (2005 Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36 : 331 335.
16. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA Laqua H (2002 Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 109 : 1256 1266.
17. Schmidt-Erfurth U, Schlötzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A Naumann GO (2003 Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44 : 4473 4480.
18. Singh AD, Nouri M, Shields CL, Shields JA Smith AF (2001 Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease. Ophthalmology 108 : 1907 1911.
19. Singh AD, Nouri M, Shields CL, Shields JA Perez N (2002 Treatment of retinal capillary hemangioma. Ophthalmology 109 : 1799 1806.
20. Webster AR, Maher ER, Bird AC, Gregor ZJ Moore AT (1999 A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology 106 : 623 629.
21. Ziemssen F, Voelker M, Inhoffen W, Bartz-Schmidt KU Gelisken F (2007 Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy. Eye 21 : 1125 1126.